Diagnosis dan Tatalaksana Sindrom Brugada
DOI:
https://doi.org/10.55175/cdk.v46i5.467Keywords:
Fibrilasi ventrikel, henti jantung mendadak, sindrom brugadaAbstract
Sindrom Brugada (SB) adalah abnormalitas listrik jantung bawaan yang langka. SB merupakan salah satu penyebab utama kematian mendadak pada usia muda tanpa penyakit jantung organik. SB dapat bersifat asimptomatik ataupun simptomatik. Beberapa pasien dapat mengalami sinkop, bahkan aritmia yang mengancam nyawa seperti fibrilasi ventrikel. EKG menjadi kunci utama diagnosis SB. Diperlukan stratifikasi risiko dan strategi lanjutan untuk mencegah henti jantung mendadak.
Brugada syndrome (BS) is a rare inherited abnormality of heart electrical activity. BS is one of the leading causes of sudden cardiac death among youth without underlying organic heart disease. BS can be asymptomatic or symptomatic. Some patients may experience syncope, even lifethreatening arrhythmia such as ventricular fibrillation. ECG test is the main key of diagnosis. Risk stratification and further strategies are needed to prevent sudden cardiac death.
Downloads
References
Brugada R, Campuzano O, Sarquella-Brugada G, Brugada J, Brugada P. Brugada syndrome. Methodist DeBakey Cardiovasc J. 2014;10(1):25-8.
Kurita T, Shimuzu W, Inagaki M, Suyama K, Taguchi A, Satomi K, et al. The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome. J Am Coll Cardiol. 2002;40(2):330-4.
Antzelevitch C. Brugada syndrome. Pacing Clin Electrophysiol. 2006;29(10):1130-59.
Fowler SJ, Priori SG. Clinical spectrum of patients with a Brugada ECG. Curr Opin Cardiol. 2009;24:74–81.
Fauchier L, Isorni MA, Clementy N, Pierre B, Simeon E, Babuty D. Prognostic value of programmed ventricular stimulation in Brugada syndrome according to clinical presentation: An updated meta-analysis of worldwide published data. Int J Cardiol. 2013;168:3027–9.
Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U, et al Natural history of Brugada syndrome: Insights for risk stratification and management. Circulation 2002;105:1342–7.
Obeyesekere MN, Klein GJ, Modi S, Leong-Sit P, Gula L, Yee R, et al. How to perform and interpret provocative testing for the diagnosis of brugada syndrome, long-qt syndrome, and catecholaminergic polymorphic ventricular tachycardia. Circ Arrhythm Electrophysiol. 2011;4:958-64.
Kusano K. Brugada syndrome: Recent understanding of pathophysiological mechanism and treatment. Journal of Arrhythmia. 2013;29(2):77-82.
Batchvarov VN. The brugada syndrome-diagnosis, clinical implications and risk stratification. Eur Cardiol. 2014;9(2):82-7.
Gourraud JB, Barc J, Thollet A, Marec H, Probst V. Brugada syndrome: Diagnosis, risk stratification and management. Arch Cardiovasc Disc. 2017;110:188-95.
Ozyilmaz I, Akyol B, Ergul Y. Sudden cardiac arrest while eating a hot dog: A rare presentation of brugada syndrome in a child. Pediatrics. 2017;140(4):e20162485
Mizusawa Y, Wilde AAM. Brugada syndrome. Circ Arrhythm Electrophysiol. 2012;5:606-16.
Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C. HRS/EHRA/APHRS Expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm. 2013;10(12):1932-63.
Vira A, Rahman E. Brugada syndrome: Diagnosis and management. The Medicine Forum. 2017;18:45-7.
Probst V, Veltmann C, Eckardt L, Meregalli PG, Gaita F, Tan HL, et al. Long term prognosis of patients diagnosed with brugada syndrome: results from the finger brugada syndrome registry. Circulation. 2010;121:635-43.
Benito B, Sarkozy A, Mont L, Henkens S, Berruezo A, Tamborero D, et al. Gender differences in clinical manifestations of brugada syndrome. JACC. 2008;52(19):1567-73.
Andorin A, Behr ER, Denjoy I, Crotti L, Dagradi F, Jesel L, et al. Impact of clinical and genetic findings on the management of young patients with brugada syndrome. Heart Rhythm 2016;13:1274-82.
Conte G, DEA C, Sieira J, Levinstein M, Chierchia GB, DI Giovanni G, et al. Clinical characteristics, management, and prognosis of elderly patients with Brugada syndrome. J Cardiovasc Electrophysiol. 2014;25:514-9.
Priori SG, Gasparini M, Napolitano C, Della Bella P, Ottonelli AG, Sassone B, et al. Risk stratification in brugada syndrome: Results of the PRELUDE (programmed electrical stimulation predictive value) registry. J Am Coll Cardiol. 2012;59:37-45.
Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace. 2011;13(8):1077-109.
Brugada P, Benito B, Buraga R, Brugada J. Brugada syndrome: Update 2009. Hellenic J Cardiol. 2009;50:352-72.
Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;36:2793-867.
Postema P, Wolpert C, Amin A, Probst V, Broggrefe M, Roden DM. Drugs and Brugada syndrome patients: Review of the literature, recommendations and up-to-date website (www.brugadadrugs.org). Heart Rhythm. 2009;6(9):1335-41.
Vohra J, Rajagopalan S. Update on the diagnosis and management of Brugada syndrome. Heart, Lung and Circulation. 2015;24:1141-8.
Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72:1677–749.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 https://creativecommons.org/licenses/by-nc/4.0/
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
